Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Best of IASLC WCLC 2016
lungcanc
IASLC 18th World Conference on Lung Cancer
First School of Nursing to Be Held at 2019 Latin American Conference on Lung Cancer
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
IASLC 2019 Mesothelioma Meeting Offers Innovative Approach for Rapid Learning
The Long Road Home
lungcanc
WCLC 2016 Together Against Lung Cancer
lungcanc
IASLC and APLCC Present 7th IASLC Asia Pacific Lung Cancer Conference
lungcanc
Highlights from IASLC WCLC 2016
lungcanc
Inaugural Africa Conference: Finding Parallels Among Disparate Realities
lungcanc
Studies Indicate Expanding Benefit of Checkpoint Inhibitors
lungcanc
ESMO-IASLC European Lung Cancer Congress
lungcanc
First Congress of Interventional Pulmonology & EBUS and the XI South...
lungcanc
IASLC Targeted Therapies of Lung Cancer Meeting Draws Record Abstract Submissions,...
lungcanc
Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS